Edition:
United Kingdom

Carl O'Donnell

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

16 Oct 2017

Nordstrom family suspends attempt to take U.S. retailer private

Nordstrom Inc said on Monday that a founding family group had suspended attempts to take the U.S. department store operator private because of difficulties in arranging debt financing for its bid ahead of the key holiday shopping season.

04 Oct 2017

Exclusive: Brookfield Property Partners explores options for office assets - sources

Brookfield Property Partners LP is considering options for its office properties in the Northeastern United States that include the potential sale of a stake that could value the portfolio at as much as $10 billion, people familiar with the matter said.

04 Oct 2017

Exclusive: Brookfield Property Partners explores options for office assets - sources

Brookfield Property Partners LP is considering options for its office properties in the northeastern United States that include the potential sale of a stake that could value the portfolio at as much as $10 billion, people familiar with the matter said.

29 Sep 2017

Exclusive: Immunotherapy developer Dynavax explores options for Hepatitis B drug-sources

Dynavax Technologies Corporation, a biotechnology company focused on drugs that harness the immune system to combat disease, is reviewing strategic options for its hepatitis B vaccine, which could include a potential sale or licensing deal, people familiar with the matter said.

29 Sep 2017

Exclusive: Activist Snow Park builds stake in Cedar Realty Trust - sources

Snow Park Capital Partners LP has built a stake in retail-focused real estate investment trust Cedar Realty Trust Inc and is urging it to explore strategic options, including a potential sale, according to two people familiar with the matter.

22 Sep 2017

Health benefits manager CareCentrix explores sale: sources

CareCentrix Inc, a U.S. benefits manager majority owned by private equity firm Summit Partners, is exploring a sale that could value it at around $1 billion, including debt, people familiar with the matter said on Friday.

15 Sep 2017

Horizon Pharma weighs sale of primary care unit -sources

Specialty drugmaker Horizon Pharma PLC is working with investment bank Morgan Stanley to review strategic options for its primary care drugs business, including a potential sale of the unit, people familiar with the matter said on Friday.

14 Sep 2017

Healthcare tech company Navicure nears deal to buy ZirMed: sources

Navicure, a healthcare technology company backed by Bain Capital, is nearing a deal to acquire ZirMed Inc that will value it at around $750 million, people familiar with the matter said on Wednesday.

14 Sep 2017

Tenet Healthcare hires advisers to explore options: source

Tenet Healthcare Corp has hired advisers to explore strategic alternatives, including a potential sale of the U.S. hospital operator, a person familiar with the matter said on Wednesday.

13 Sep 2017

Healthcare tech company Navicure nears deal to buy ZirMed -sources

Sept 13 Navicure, a healthcare technology company backed by Bain Capital, is nearing a deal to acquire healthcare revenue management company ZirMed Inc that will value it at around $750 million, people familiar with the matter said on Wednesday.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,524.45 + 1.22 +0.02%
DAX 13,003.14 -- --%
CAC 40 5,386.81 + 0.00 +0.00%
TR Europe 184.41 -0.69 -0.37%
GBP/USD 1.3219 +0.17%
GBP/EUR 1.1237 +0.06%
EUR/USD 1.1763 +0.14%
Gold 1,277.70 +0.00 +0.00%
Oil 51.97 +0.07 +0.13%
Corn 351.50 +0.25 +0.07%